NASDAQ:OMIC Singular Genomics Systems (OMIC) Stock Price, News & Analysis → The Greatest LEGAL Transfer of Wealth in History is Underway (From Stansberry Research) (Ad) Free OMIC Stock Alerts $0.35 +0.01 (+2.39%) (As of 01:16 PM ET) Add Compare Share Share Today's Range$0.32▼$0.3550-Day Range$0.32▼$0.5052-Week Range$0.30▼$1.05Volume43,310 shsAverage Volume122,794 shsMarket Capitalization$26.01 millionP/E RatioN/ADividend YieldN/APrice Target$0.63 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Singular Genomics Systems alerts: Email Address Singular Genomics Systems MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside78.1% Upside$0.63 Price TargetShort InterestHealthy0.98% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.25 out of 5 starsMedical Sector471st out of 905 stocksAnalytical Instruments Industry15th out of 26 stocks 3.0 Analyst's Opinion Consensus RatingSingular Genomics Systems has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageSingular Genomics Systems has only been the subject of 2 research reports in the past 90 days.Read more about Singular Genomics Systems' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.98% of the float of Singular Genomics Systems has been sold short.Short Interest Ratio / Days to CoverSingular Genomics Systems has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Singular Genomics Systems has recently decreased by 37.89%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSingular Genomics Systems does not currently pay a dividend.Dividend GrowthSingular Genomics Systems does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OMIC. Previous Next 0.6 News and Social Media Coverage MarketBeat Follows1 people have added Singular Genomics Systems to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Singular Genomics Systems insiders have not sold or bought any company stock.Percentage Held by Insiders22.20% of the stock of Singular Genomics Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions65.80% of the stock of Singular Genomics Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Singular Genomics Systems' insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Singular Genomics Systems is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Singular Genomics Systems is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSingular Genomics Systems has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Singular Genomics Systems' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchThe Greatest LEGAL Transfer of Wealth in History is UnderwayWhat's the #1 Stock to Build Generational Wealth RIGHT NOW? One Wall Street millionaire will give you a surprising answer. He bought AAPL at $0.35 and AMZN under $2.50. Recently, he sat down for an exclusive interview, revealing EXACTLY where to put your money this year. An investment vehicle he's so confident in, he says he'd put 50% of his kids' inheritance into this stock.You can get the name and ticker for free, right here. About Singular Genomics Systems Stock (NASDAQ:OMIC)Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.Read More OMIC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OMIC Stock News HeadlinesMay 29, 2024 | globenewswire.comSingular Genomics to Present at the Goldman Sachs Global Healthcare ConferenceMay 16, 2024 | insidermonkey.comSingular Genomics Systems, Inc. (NASDAQ:OMIC) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comQ1 2024 Singular Genomics Systems Inc Earnings CallMay 15, 2024 | finance.yahoo.comSingular Genomics Systems Inc (OMIC) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...May 14, 2024 | investorplace.comOMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q1 2024May 14, 2024 | markets.businessinsider.comHere's what Wall Street expects from Singular Genomics Systems's earnings reportMay 14, 2024 | globenewswire.comSingular Genomics Reports Recent Highlights and First Quarter 2024 Financial ResultsMay 1, 2024 | finance.yahoo.comSingular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024April 20, 2024 | investing.comSingular Genomics Systems Inc (OMIC)April 17, 2024 | msn.comSingular Genomics Systems (OMIC) Price Target Increased by 25.93% to 0.87April 4, 2024 | msn.comDeciphering genomic language: New AI system unlocks biology’s source codeMarch 20, 2024 | seekingalpha.comSingular Genomics Systems, Inc. (OMIC) Q4 2023 Earnings Call TranscriptMarch 20, 2024 | finance.yahoo.comSingular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call TranscriptMarch 19, 2024 | finanznachrichten.deSingular Genomics Systems, Inc.: Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial ResultsMarch 18, 2024 | benzinga.comSingular Genomics Sys: Q4 Earnings InsightsMarch 18, 2024 | globenewswire.comSingular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial ResultsMarch 17, 2024 | markets.businessinsider.comSingular Genomics Systems earnings: here's what to expectMarch 15, 2024 | benzinga.comPreview: Singular Genomics Sys's EarningsMarch 15, 2024 | msn.comSingle-cell RNA-seq reveals transcriptomic modulation of Alzheimer's disease by activated protein CMarch 11, 2024 | msn.comNovel gene editing tool analyzes sperm health in animalsMarch 5, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), ZimVie Inc (ZIMV) and Veeva Systems (VEEV)March 4, 2024 | globenewswire.comSingular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024February 24, 2024 | wsj.comSingular Genomics Systems Inc.February 5, 2024 | finanznachrichten.deSingular Genomics Systems, Inc.: Singular Genomics Unveils G4X Spatial Sequencer, Transforming the Landscape of In Situ Multiomic AnalysisJanuary 8, 2024 | msn.comSingular Genomics reports instrument shipments, preliminary Q4 revenueSee More Headlines Receive OMIC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today6/11/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolNASDAQ:OMIC CUSIPN/A CIK1850906 Websingulargenomics.com Phone858-333-7830FaxN/AEmployees255Year FoundedN/APrice Target and Rating Average Stock Price Target$0.63 High Stock Price Target$0.75 Low Stock Price Target$0.50 Potential Upside/Downside+78.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-94,820,000.00 Net Margins-3,863.90% Pretax Margin-3,863.90% Return on Equity-51.10% Return on Assets-35.86% Debt Debt-to-Equity Ratio0.05 Current Ratio10.35 Quick Ratio9.54 Sales & Book Value Annual Sales$2.91 million Price / Sales8.94 Cash FlowN/A Price / Cash FlowN/A Book Value$2.44 per share Price / Book0.14Miscellaneous Outstanding Shares74,090,000Free Float57,644,000Market Cap$26.01 million OptionableOptionable Beta1.40 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Andrew Spaventa (Age 39)Founder, CEO, President & Chairperson of the Board Comp: $685.93kDr. David L. Barker Ph.D. (Age 82)Founder, Member of Scientific Advisory Board & Independent Director Comp: $63.75kDr. Eli N. Glezer Ph.D. (Age 55)Founder, Chief Scientific Officer & Chair of Scientific Advisory Board Comp: $496.5kMr. Dalen Meeter (Age 46)Chief Financial Officer Comp: $434.39kJyotsna GhaiChief Operating OfficerMr. Jorge Velarde Jr. (Age 57)MBA, Senior Vice President of Corporate Development & Strategy Mr. Jeff BullardHead of SalesMr. Vincent Brancaccio (Age 41)Head of Human Resources Mr. Samuel Ropp Ph.D. (Age 50)Chief Commercial Officer More ExecutivesKey CompetitorsCara TherapeuticsNASDAQ:CARAAkoya BiosciencesNASDAQ:AKYABionano GenomicsNASDAQ:BNGOPrenetics GlobalNASDAQ:PRERapid Micro BiosystemsNASDAQ:RPIDView All CompetitorsInsidersEli N GlezerBought 200,000 shares on 11/16/2023Total: $86,000.00 ($0.43/share)Andrew SpaventaBought 43,468 shares on 11/16/2023Total: $17,821.88 ($0.41/share)Kim P KamdarSold 77,991 sharesTotal: $44,454.87 ($0.57/share)Kim P KamdarSold 353,657 sharesTotal: $212,194.20 ($0.60/share)View All Insider Transactions OMIC Stock Analysis - Frequently Asked Questions Should I buy or sell Singular Genomics Systems stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OMIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. View OMIC analyst ratings or view top-rated stocks. What is Singular Genomics Systems' stock price target for 2024? 2 equities research analysts have issued 1 year target prices for Singular Genomics Systems' stock. Their OMIC share price targets range from $0.50 to $0.75. On average, they expect the company's stock price to reach $0.63 in the next year. This suggests a possible upside of 78.1% from the stock's current price. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. How have OMIC shares performed in 2024? Singular Genomics Systems' stock was trading at $0.4601 on January 1st, 2024. Since then, OMIC stock has decreased by 23.7% and is now trading at $0.3510. View the best growth stocks for 2024 here. Are investors shorting Singular Genomics Systems? Singular Genomics Systems saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 414,400 shares, a decrease of 37.9% from the April 30th total of 667,200 shares. Based on an average trading volume of 126,300 shares, the days-to-cover ratio is currently 3.3 days. Approximately 1.0% of the shares of the stock are short sold. View Singular Genomics Systems' Short Interest. When is Singular Genomics Systems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our OMIC earnings forecast. How were Singular Genomics Systems' earnings last quarter? Singular Genomics Systems, Inc. (NASDAQ:OMIC) issued its quarterly earnings data on Tuesday, May, 14th. The company reported ($0.34) earnings per share (EPS) for the quarter. The business earned $0.44 million during the quarter, compared to analyst estimates of $0.50 million. Singular Genomics Systems had a negative trailing twelve-month return on equity of 51.10% and a negative net margin of 3,863.90%. When did Singular Genomics Systems IPO? Singular Genomics Systems (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. The company issued 8,500,000 shares at $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. How do I buy shares of Singular Genomics Systems? Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OMIC) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersThe Greatest LEGAL Transfer of Wealth in History is UnderwayWhat's the #1 Stock to Build Generational Wealth RIGHT NOW? One Wall Street millionaire will give you a sur...Stansberry Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Singular Genomics Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Singular Genomics Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.